Riskpilot← Back to searchSign inGet full accessASKERGYNEKOLOGEN AS
ASActiveOrg 922704902Knud Askers Vei 28A, 1383 AskerMedical specialists activities · NACE 8622Est. 20195 employees
Revenue 2024
NOK 4,6M
-4% vs 2023
EBITDA margin
-1.2%
+98% vs 2023
Equity ratio
-704.7%
Financial strength
Net profit 2024
NOK -186K
+93% vs 2023
| Revenue | NOK 4,6M | -4% |
| EBITDA | NOK -57K | +98% |
| Net profit | NOK -186K | +93% |
| Total assets | NOK 349K | -36% |
| Equity | NOK -2,5M | -8% |
| Employees | 5 | — |
Legal name
ASKERGYNEKOLOGEN AS
Org number
922704902
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
4. mai 2019
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av kontorfellesskap, herunder spesialistbehandling innen gynekologi og undervisning. I tillegg kan virksomheten drives innen kjøp og salg av aksjer, andre immaterielle eiendeler, kunst, samt investering, drift/utleie og salg av eiendom og andre objekter.
Address
Knud Askers Vei 28A, 1383 Asker
Phone
+4766787933
Email
post@askergynekologen.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 988 | 3 961 | 4 762 | 4 785 | 4 573 |
| Staff expenses | −1 191 | −1 328 | −1 385 | −1 407 | −1 184 |
| EBITDA | 294 | 517 | −6 | −2 348 | −57 |
| Depreciation & amort. | −164 | −200 | −221 | −219 | −131 |
| EBIT | 130 | 317 | −226 | −2 567 | −187 |
| Net financials | −5 | −2 | −5 | −9 | 1 |
| Profit before tax | 124 | 315 | −231 | −2 577 | −186 |
| Tax | 27 | 69 | −0 | −0 | −0 |
| Net profit | 97 | 245 | −231 | −2 577 | −186 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 218 | 1 251 | 973 | 544 | 349 |
| Equity | 286 | 532 | 301 | −2 276 | −2 462 |
| Long-term debt | 476 | 350 | 230 | 2 481 | 2 642 |
| Short-term debt | 455 | 369 | 443 | 339 | 170 |
| Total debt | 931 | 719 | 673 | 2 820 | 2 812 |
EBITDA margin
-1.2%
This company
15.8%
Market median
-108% vs market
20202024
Equity ratio
-704.7%
This company
38.2%
Market median
-1945% vs market
20202024
Return on equity
-18635000.0%
This company
18.4%
Market median
-101277274% vs market
20202024
Net profit margin
-4.1%
This company
8.1%
Market median
-151% vs market
20202024
Asset turnover
13.09×
This company
1.12×
Market median
+1069% vs market
20202024
Debt / equity
1.14×
This company
0.62×
Market median
-84% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2024 | |
| Chairman | 2019 | |
| Former (1) | ||
| Deputy Chairman | 2019 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ASKERGYNEKOLOGEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Vibeke Rognan | Deputy Chairman | 0 companies |
| Trond Olaf Haugland | Board of Directors | 0 companies |
| Kristin Ramm | Chairman | 0 companies |